BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 11464181)

  • 21. Sustained remission of Sézary syndrome.
    Bouwhuis SA; McEvoy MT; Davis MD
    Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α.
    Riley CH; Hansen M; Brimnes MK; Hasselbalch HC; Bjerrum OW; Straten PT; Svane IM; Jensen MK
    Eur J Haematol; 2015 Mar; 94(3):227-34. PubMed ID: 25082025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma.
    Di Renzo M; Rubegni P; De Aloe G; Paulesu L; Pasqui AL; Andreassi L; Auteri A; Fimiani M
    Immunology; 1997 Sep; 92(1):99-103. PubMed ID: 9370930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation.
    Dummer R; Kohl O; Gillessen J; Kägi M; Burg G
    Arch Dermatol; 1993 Apr; 129(4):433-6. PubMed ID: 8466213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD7-positive Sézary syndrome with a Th1 cytokine profile.
    Yagi H; Tokura Y; Furukawa F; Takigawa M
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):368-74. PubMed ID: 8655729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4.
    Showe LC; Fox FE; Williams D; Au K; Niu Z; Rook AH
    J Immunol; 1999 Oct; 163(7):4073-9. PubMed ID: 10491012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome.
    Ni X; Jorgensen JL; Goswami M; Challagundla P; Decker WK; Kim YH; Duvic MA
    Clin Cancer Res; 2015 Jan; 21(2):274-85. PubMed ID: 25376389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma.
    Vowels BR; Lessin SR; Cassin M; Jaworsky C; Benoit B; Wolfe JT; Rook AH
    J Invest Dermatol; 1994 Nov; 103(5):669-73. PubMed ID: 7963654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis.
    Durgin JS; Jariwala NN; Wysocka M; Zhang KK; Maity A; Benoit B; Plastaras JP; Lewis DJ; Rosenthal JM; Teague JE; Berg S; Del Guzzo C; Kim EJ; Vittorio C; Haun PL; Samimi SS; Villasenor-Park J; Inverso J; Clark RA; Rook AH
    JAMA Dermatol; 2021 Jan; 157(1):90-95. PubMed ID: 33112366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follow-up of the T-cell clonality in Sezary patients treated by extracorporeal photopheresis using a new assay: the immunoscope technique.
    Ingen-Housz-Oro S; Bussel A; Flageul B; Dubertret L; Michel L; Gachelin G; Kourilsky P; Bachelez H; Musette P
    Transfus Apher Sci; 2003 Feb; 28(1):35-42. PubMed ID: 12620267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome.
    Fritz TM; Kleinhans M; Nestle FO; Burg G; Dummer R
    Br J Dermatol; 1999 Jun; 140(6):1144-7. PubMed ID: 10354086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosomally clonal T cells in the skin, blood, or lymph nodes of two Sezary syndrome patients express CD45RA, CD45RO, CDw150, and interleukin-4, but no interleukin-2 or interferon-gamma.
    Karenko L; Nevala H; Raatikainen M; Franssila K; Ranki A
    J Invest Dermatol; 2001 Jan; 116(1):188-93. PubMed ID: 11168816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cells.
    Fox FE; Kubin M; Cassin M; Niu Z; Trinchieri G; Cooper KD; Rook AH
    J Interferon Cytokine Res; 1999 Apr; 19(4):407-15. PubMed ID: 10334392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photoactivational cytokine-modulatory action of 8-methoxypsoralen plus ultraviolet A in lymphocytes, monocytes, and cutaneous T cell lymphoma cells.
    Tokura Y; Seo N; Yagi H; Takigawa M
    Ann N Y Acad Sci; 2001 Sep; 941():185-93. PubMed ID: 11594572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
    Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
    J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
    [No Abstract]   [Full Text] [Related]  

  • 39. Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis.
    Echchakir H; Bagot M; Dorothée G; Martinvalet D; Le Gouvello S; Boumsell L; Chouaib S; Bensussan A; Mami-Chouaib F
    J Invest Dermatol; 2000 Jul; 115(1):74-80. PubMed ID: 10886511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transition of Sézary syndrome into mycosis fungoides after complete clinical and molecular remission under extracorporeal photophoresis.
    Assaf C; Hummel M; Zemlin M; Steinhoff M; Geilen CC; Stein H; Orfanos CE
    J Clin Pathol; 2004 Dec; 57(12):1325-8. PubMed ID: 15563677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.